151 related articles for article (PubMed ID: 35715177)
1. Risk factors for COVID-19 hospitalisations and deaths in Mexican children and adolescents: retrospective cross-sectional study.
Martínez-Valdez L; Richardson López Collada V; Castro-Ceronio LE; Rodríguez Gutiérrez ÁM; Bautista-Márquez A; Hernandez-Avila M
BMJ Open; 2022 Jun; 12(6):e055074. PubMed ID: 35715177
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of hospitalization and death in Mexican children and adolescents with COVID-19 and comorbidities.
Méndez-Hernández P; Hernández-Galdamez DR; González-Block MA; Romo-Dueñas DK; Cahuantzi-Tamayo RM; Texis-Morales O; Medina-Urzúa JJ; Cerón-Meza R; Hernández-Vicente IA; Lumbreras-Guzmán M
Bol Med Hosp Infant Mex; 2023; 80(2):105-114. PubMed ID: 37155722
[TBL] [Abstract][Full Text] [Related]
3. Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study.
Sousa BLA; Brentani A; Costa Ribeiro CC; Dolhnikoff M; Grisi SJFE; Ferrer APS; Ferraro AA
BMJ Open; 2021 Sep; 11(9):e050724. PubMed ID: 34489291
[TBL] [Abstract][Full Text] [Related]
4. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.
Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814
[TBL] [Abstract][Full Text] [Related]
5. Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study.
Serván-Mori E; Seiglie JA; Gómez-Dantés O; Wirtz VJ
J Epidemiol Community Health; 2022 Jan; 76(1):16-23. PubMed ID: 34266980
[TBL] [Abstract][Full Text] [Related]
6. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
7. Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study.
Hernández-Vásquez A; Azañedo D; Vargas-Fernández R; Bendezu-Quispe G
J Prev Med Public Health; 2020 Jul; 53(4):211-219. PubMed ID: 32752589
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with death in children with COVID-19 in Mexico.
Rivas-Ruiz R; Roy-García IA; Ureña-Wong KR; Aguilar-Ituarte F; Anda GFV; Gutiérrez-Castrellón P; Mancilla-Ramírez J; Moreno-Espinosa S
Gac Med Mex; 2020; 156(6):516-522. PubMed ID: 33877105
[TBL] [Abstract][Full Text] [Related]
9. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
Vera-Zertuche JM; Mancilla-Galindo J; Tlalpa-Prisco M; Aguilar-Alonso P; Aguirre-García MM; Segura-Badilla O; Lazcano-Hernández M; Rocha-González HI; Navarro-Cruz AR; Kammar-García A; Vidal-Mayo JJ
Epidemiol Infect; 2021 Apr; 149():e109. PubMed ID: 33913410
[TBL] [Abstract][Full Text] [Related]
10. A panoramic view of hospitalized young children in the metropolitan area of the valley of Mexico during COVID-19.
Padilla-Rivas GR; Santoyo-Suarez MG; Benitez-Chao DF; Galan-Huerta K; Villareal HF; Garza-Treviño EN; Islas JF
IJID Reg; 2023 Dec; 9():72-79. PubMed ID: 37928801
[TBL] [Abstract][Full Text] [Related]
11. Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages.
Sosa-Rubí SG; Seiglie JA; Chivardi C; Manne-Goehler J; Meigs JB; Wexler DJ; Wirtz VJ; Gómez-Dantés O; Serván-Mori E
Diabetes Care; 2021 Feb; 44(2):373-380. PubMed ID: 33208487
[TBL] [Abstract][Full Text] [Related]
12. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P
Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and factors associated with COVID-19-related mortality and hospital admission during the first two epidemic waves in 5 rural provinces in Indonesia: A retrospective cohort study.
Surendra H; Praptiningsih CY; Ersanti AM; Rahmat M; Noviyanti W; Harmani JAD; Mansur ENA; Suleman YY; Sudrani S; Rosalina R; Mukhtar I; Rosadi D; Fauzi L; Elyazar IRF; Hawley WA; Wibisono H
PLoS One; 2023; 18(3):e0283805. PubMed ID: 36996045
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and mortality risk factors in patients aged less than 18 years with COVID-19 in Mexico and Mexico City.
Wong-Chew RM; Noyola DE; Villa AR
An Pediatr (Engl Ed); 2022 Aug; 97(2):119-128. PubMed ID: 35869013
[TBL] [Abstract][Full Text] [Related]
15. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
COVID-19 National Incident Room Surveillance Team
Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
[TBL] [Abstract][Full Text] [Related]
16. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
17. Hospitalisation and mortality among privately insured individuals with COVID-19 in the United States: The role of intellectual disabilities and Neurogenetic disorders.
Davis A; Copeland-Linder N; Phuong K; Belcher H; van Eck K
J Intellect Disabil Res; 2024 Jun; 68(6):573-584. PubMed ID: 38369907
[TBL] [Abstract][Full Text] [Related]
18. Decreased risk of COVID-19 pneumonia in children and adolescents during the Delta variant emergence.
Murillo-Zamora E; Trujillo X; Huerta M; Ríos-Silva M; Baltazar-Rodríguez LM; Guzmán-Esquivel J; Benites-Godínez V; Ortega-Ramírez AD; Mendoza-Cano O
Public Health; 2022 Mar; 204():9-11. PubMed ID: 35085915
[TBL] [Abstract][Full Text] [Related]
19. Does comorbidity burden explain the higher COVID-19 mortality risk among men? A retrospective cross-sectional analysis of a well-defined cohort of patients in Bronx, New York.
Vasa A; Kini M; Neugarten J; Bellin E; Golestaneh L
BMJ Open; 2022 Sep; 12(9):e063862. PubMed ID: 36581961
[TBL] [Abstract][Full Text] [Related]
20. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.
Kompaniyets L; Agathis NT; Nelson JM; Preston LE; Ko JY; Belay B; Pennington AF; Danielson ML; DeSisto CL; Chevinsky JR; Schieber LZ; Yusuf H; Baggs J; Mac Kenzie WR; Wong KK; Boehmer TK; Gundlapalli AV; Goodman AB
JAMA Netw Open; 2021 Jun; 4(6):e2111182. PubMed ID: 34097050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
